Recursion Pharmaceuticals
Price & Volume
Stats
See more52W Range | $3.79-$12.36 |
Market Cap | $2.5B |
Shares Short | 126M |
Financials
See moreRevenue (12 Mos) | $64.5M |
Revenue Growth (YoY) | 33.3% |
Gross Profit (12 Mos) | -$433.4M |
Diluted EPS | -$1.81 |
News
See moreYahoo Finance • 5 days ago
AI in Biotechnology Market to Reach $11.4 Billion by 2030
Yahoo Finance • 7 days ago
Jim Cramer on Recursion Pharmaceuticals: “Now, It’s a Meme Stock”
Yahoo Finance • 8 days ago
Recursion Pharmaceuticals (RXRX) Surges 14% Ahead of Earnings
Yahoo Finance • 13 days ago
Recursion Pharmaceuticals (RXRX) Extends Gains, Jumps 15.28% on Major AI Event
About
CEO | Dr. Christopher C. Gibson Ph.D. |
CFO | Mr. Ben R. Taylor |
Address | 41 South Rio Grande Street, Salt Lake City, UT, United States, 84101 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 800 |
